humanitarian
Archived signal Translated · Español · 2–5m lag
Medicinas humanas Informe Público Europeo de Evaluación (EPAR): Delstrigo, doravirina,lamivudina, tenofovir disoproxil, Fecha de autorización: 22/11/2018, Revisión: 15, Estado: Autorizado
Medicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Ahzantive, Aflibercept, Fecha de autorización: 13/01/2025, Revisión: 6, Estado: Autorizado
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewMedicinas humanas Informe Público Europeo de Evaluación (EPAR): Delstrigo, doravirina,lamivudina, tenofovir disoproxil, Fecha de autorización: 22/11/2018, Revisión: 15, Estado: AutorizadoEMA What Is NewMedicinas humanas Informe Público Europeo de Evaluación (EPAR): Delstrigo, doravirina,lamivudina, tenofovir disoproxil, Fecha de autorización: 22/11/2018, Revisión: 15, Estado: AutorizadoEMA What Is NewHuman medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation: 29/06/2007, Revision: 32, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation: 29/06/2007, Revision: 32, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 4, Status: AuthorisedEMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Eltrombopag Accord, eltrombopog, Fecha de autorización: 28/03/2025, Revisión: 7, Estado: AutorizadoEMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Eltrombopag Accord, eltrombopog, Fecha de autorización: 28/03/2025, Revisión: 7, Estado: AutorizadoEMA What Is NewHuman medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 17, Status: Au…EMA What Is NewHuman medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 17, Status: Au…2 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources